Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. - Wikidata - wikimedia - TriplyDB

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

http://www.wikidata.org/entity/Q33187603

about

Proteomics Research in Schizophrenia Neuroproteomics in neurotrauma Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart.Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.The impact of blood contamination on the proteome of cerebrospinal fluid.Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood.Proteome analysis of chick embryonic cerebrospinal fluid.Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation.Analysis of chicken serum proteome and differential protein expression during development in single-comb White Leghorn hens.Proteomic analysis of the mouse brain following protein enrichment by preparative electrophoresis.Proteomics in clinical trials and practice: present uses and future promise.An integrated map of the murine hippocampal proteome based upon five mouse strains.Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.Biomarker discovery in psychiatric disorders.Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis.Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.Schizophrenia proteomics: biomarkers on the path to laboratory medicine?Differences in serum protein 2D gel electrophoresis patterns of Przewalski's (Mongolian wild horse) and thoroughbred horses.Application of proteomics technologies in the investigation of the brain.Toxicoproteomics: proteomics applied to toxicology and pathology.Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.Translational research in central nervous system drug discovery.Proteomics-driven progress in neurodegeneration research.Genetics, transcriptomics, and proteomics of Alzheimer's disease Proteomic research in psychiatry.Proteomic studies on the development of the central nervous system and beyond.Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?Systems biology, bioinformatics, and biomarkers in neuropsychiatry.Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Study of rat hypothalamic proteome by HPLC/ESI ion trap and HPLC/ESI-Q-TOF MS.Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.Characterization of mature rat oligodendrocytes: a proteomic approach.

P2860

Q26766821-1417DFBD-834D-405B-9A6B-894A3B991D45 Q28299064-56490D74-40B0-4EC3-A4B5-84372133099B Q30915732-9A5AF14B-2C8E-4565-B943-13216A92D09B Q31052140-D976ECF8-63A0-4FA4-9688-EF39C0D5AC1B Q31143697-21884C5B-F7FF-4658-8398-9284255084FC Q33217620-FF10F1D3-246B-4E5F-9B5F-B1DE578F2167 Q33227168-28ECD80D-4724-478C-8016-D3F7EDD9CAA4 Q33230150-B3FFD81B-772D-424A-B399-827710F5665B Q33233800-C7785C87-F29D-4C2A-BCDE-49ADBD7AE0D8 Q33235542-9CF3FB4B-84CF-466D-8435-B39CE44093ED Q33245305-CB578C1D-322C-4556-89B9-D941E6CD6C75 Q33248674-763F163B-EDA5-4B58-8788-A6DE665EEABB Q33294428-CE7D9EA5-0781-4EDC-B241-F9674C701892 Q33338835-3800092C-11CE-4104-86CD-B5B2B266E81B Q33371612-6C57FD88-BF19-4924-A22E-7736E516EF1E Q33402521-51832973-C403-4D84-982E-B6C5AE00FBB6 Q33998390-88CBF453-F6A9-4AD8-A602-0901356CABA1 Q34888915-778DC61E-D4A2-490B-8D8C-5990069825CE Q34928687-19E4D24A-10CA-4932-B456-A0EF80952040 Q34973585-F4E0D739-BE5B-4625-BA0E-732F57019CA4 Q35532618-75BAC23F-137B-4BB5-AD40-802ACA03C10C Q35767749-F68A120C-48C8-43C1-BC69-DC05CDE6C83E Q35973576-12497680-7D9D-416F-A317-89E2FCBAE9C8 Q36121837-C614E47F-761B-4DDC-B5F6-99CD312C9B00 Q36168593-4CB76A57-1DF0-4012-8848-A89C762F61DA Q36401418-36F987C0-8A22-41E0-8B66-E74650D19346 Q36429201-B639147A-BDBF-4519-B2E3-7A5CD5403AB6 Q36466472-2A2571DF-54CD-4DC3-A2B8-1544FFA2FB22 Q37689362-66B9C8E4-8691-4FCA-A3F4-17DA81D21F69 Q37767612-6292C392-F874-4FFD-9D96-A7C8D37A09CB Q37968946-80278D8E-6732-4B83-B3DD-17F4D2A8F422 Q38069972-C09D2037-9B7D-445A-808E-F857A787C13F Q38807041-91A342E2-A70C-4520-8A2B-D06604408240 Q38809444-2331CE2A-467E-4AA3-96F6-050F758975FA Q38844925-CB7C3D56-B456-402D-BCE9-6A61D3B85F34 Q44140058-098F2DE5-C734-4E38-B2EE-D12A5D7EF544 Q46599874-63F0039E-C5D4-4D19-926A-77ECAC0F203A Q47213104-D02B3A34-B5E7-4986-9FE8-75D34A8A1A5B Q47241901-2DC3B682-CDE3-44E1-A054-4D61BB6BD281 Q48198699-57C3E684-3C0F-4A20-BA6B-983831B3074B

P2860

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

http://www.wikidata.org/entity/Q33187603

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@ast

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@en

type

label

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@ast

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@en

prefLabel

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@ast

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@en

P1433

Q33187603-77D45613-9B8A-4CEA-BF74-65C16D8670CA

P1476

Q33187603-ED108B45-2FF6-4BA4-B07A-E286CB8B1414

P2093

Q33187603-026F04D9-90C2-4AFB-BDF9-3F996E0DE0FA

Q33187603-0ED0E69A-A6E1-4025-8523-B3C86DB4AB28

Q33187603-192CE677-ACB0-463B-B81C-C4BA5F889B7D

Q33187603-463F0CEA-7566-4492-A3F2-E3A121F27349

Q33187603-6B002FA2-7CAF-4B40-99EE-4228289D4F7E

Q33187603-9A8A217E-C3E3-488A-9502-4BA309BDEAA4

Q33187603-C4E01330-31C0-4ABC-8F14-1ECBF7B33BE0

P2860

Q33187603-02837C2C-907A-428A-97CB-7FB84C68BA17

Q33187603-361E776B-E87B-4C25-A72E-87D37C0DF26A

Q33187603-39C5475A-871D-4CB0-8E86-3A9CDFDCF459

Q33187603-3D8995E9-B4FD-4D5C-AA31-535C01AA8E08

Q33187603-47893B7A-26DE-4FBD-A6B6-3EB51A0EF1D9

Q33187603-92B46045-DE26-452E-BC9B-1CFB2EFB0AE4

Q33187603-A3EE6662-E679-4957-9F69-C14816A51E66

Q33187603-AEB51962-FFC1-445B-A2FA-CD17C8B3E82A

Q33187603-AF50021B-E21D-4685-886D-BE3900E62CC4

Q33187603-B0EABBE9-F839-45AE-8F64-BE349166013E

P2888

Q33187603-17590305-F71F-49CC-AB9A-E6C6182F76CA

P304

Q33187603-C6E8743A-739E-45FF-9246-A4B9BA870F8B

P31

Q33187603-24BBDE4E-BAE5-46EC-B7AE-86908C6924E4

P356

Q33187603-7C5EEC76-D127-4042-8895-64B5F4B945C3

P433

Q33187603-DFC0BC5C-270C-4274-9D9F-109D332E0A2E

P478

Q33187603-DA9AF4BD-BD7A-4392-BA4A-89E67777CD86

P577

Q33187603-EF21E7EA-374E-4B35-A136-43C7F6B10BAD

P698

Q33187603-A310F158-F14F-4BF7-A5DF-45644EFFD4E9

P921

Q33187603-025BE0AF-E205-45B0-821D-C2E0F44F458C

Q33187603-096FE8CB-BFBF-4011-B06F-E17800E9DBD6

Q33187603-FC1ACB06-132A-482B-A3C9-D6EE825CDC47

P356

S00726-003-0356-6

P1433

P1476

Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.

@en

P2093

Fountoulakis M

http://www.w3.org/2001/XMLSchema#string

Gu NF

http://www.w3.org/2001/XMLSchema#string

He L

http://www.w3.org/2001/XMLSchema#string

Jiang L

http://www.w3.org/2001/XMLSchema#string

Langen H

http://www.w3.org/2001/XMLSchema#string

Li HF

http://www.w3.org/2001/XMLSchema#string

Lindpaintner K

http://www.w3.org/2001/XMLSchema#string

P2860

Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints.

Analysis of the human lumbar cerebrospinal fluid proteome.

Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrom

Candidate-gene association studies of schizophrenia.

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

Advances in schizophrenia.

Protein expression in Down syndrome brain.

From neuropathology to neurodevelopment.

Proteomic analysis of the fetal brain.

P2888

s00726-003-0356-6

P304

49-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-003-0356-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12836058

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid